NY-ESO-1 specific TCR-HEK293 c...
- Article
- NY-ESO-1 specific TCR-HEK293 cell line
- Product Number
- CHEK-STP114-2VIALS
- Supplier
- Acro Biosystems
- Size
- 2 vials
- Description
- NY-ESO-1, which is also well-known as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancer-testis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLA-A2 restricted NY-ESO-1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatment-refractory melanoma patients. This cell can specifically recognize HLA-A2/NY-ESO-1. The price includes a surcharge of 350 CHF for Dry Ice delivery.
- Category
- Cell Culture
- Product Group
- Primary Cells & Cell Lines
- Application
- ELISA, FACS
- Shipping Temperature
- DRY ICE
- Supplier URL
- Visit supplier product page
Size: 2 vials
price on request